Retatrutide is Eli Lilly's triple agonist - one weekly injection that hits three receptors at once (GLP-1, GIP, glucagon)
Secondly, necrotic cells can also release HMGB1
Notably, co-administration with farnesoid X receptor (FXR) agonists or peroxisome proliferator-activated receptor (PPAR) agonists may enhance lipid metabolism regulation and anti-inflammatory effects, addressing multiple pathogenic pathways simultaneously
How do you see this impacting accessibility for Type 2 diabetes patients?
Importantly, tirzepatide is not approved for type 1 diabetes, diabetic ketoacidosis, or for use in patients under 18 years of age
But if youre selling green banana flour in a baking mix that is going to end up in a hot oven, or adding certain resistant starches to cereals that might be processed using high pressure or temperatures, the starch may not be resistant to digestion anymore, and the associated benefits will not be delivered, he points out